Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Adaptive Biotechnologies Corporation (ADPT) had Free Cash Flow of $-17.92M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$71.55M |
|
$-39.79M |
|
$20.16M |
|
$51.39M |
|
$87.32M |
|
$-15.77M |
|
$-24.17M |
|
$-39.94M |
|
$-39.94M |
|
$-39.94M |
|
$-39.94M |
|
$-39.94M |
|
$-39.94M |
|
$-15.77M |
|
$-12.19M |
|
159.86M |
|
159.86M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$420.56M |
|
$29.45M |
|
$220.12M |
|
$640.68M |
|
$87.71M |
|
$334.88M |
|
$402.30M |
|
$490.02M |
|
$150.66M |
|
$30.81M |
|
$150.66M |
|
159.06M |
|
| Cash Flow Statement Financials | |
$-15.94M |
|
$-34.33M |
|
$149.69M |
|
$73.18M |
|
$172.60M |
|
$99.42M |
|
$23.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
0.69 |
|
2.22 |
|
71.82% |
|
-22.04% |
|
-22.04% |
|
-- |
|
-55.82% |
|
-55.61% |
|
|
Free Cash Flow |
$-17.92M |
-- |
|
-- |
|
-- |
|
0.11 |
|
1.92 |
|
1.45 |
|
62.28 |
|
-26.51% |
|
-129.65% |
|
-6.23% |
|
-8.23% |
|
$0.95 |
|
$-0.11 |
|
$-0.10 |
|